These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11093690)

  • 1. Progressive appearance of overlap syndrome together with autoantibodies in a patient with fatal thrombotic microangiopathy.
    Nanke Y; Akama H; Yamanaka H; Hara M; Kamatani N
    Am J Med Sci; 2000 Nov; 320(5):348-51. PubMed ID: 11093690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistence of serum anti-DNA topoisomerase I and anti-Sm antibodies: report of 3 cases.
    Kameda H; Kuwana M; Hama N; Kaburaki J; Homma M
    J Rheumatol; 1997 Feb; 24(2):400-3. PubMed ID: 9035005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies in systemic sclerosis.
    Vázquez-Abad D; Rothfield NF
    Int Rev Immunol; 1995; 12(2-4):145-57. PubMed ID: 7650418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies and their relation to rheumatic diseases.
    McCarty GA
    Med Clin North Am; 1986 Mar; 70(2):237-61. PubMed ID: 2419715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
    Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
    J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic lupus erythematosus and overlapping syndrome].
    Katsu M; Fujii T
    Nihon Rinsho; 1976 Jun; 34(6):1124-30. PubMed ID: 9526
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous presentation of thrombotic thrombocytopenic purpura and systemic lupus erythematosus.
    Bray VJ; West SG; Kristo DA
    South Med J; 1994 Aug; 87(8):827-30. PubMed ID: 8052895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.
    Doran M; Wordsworth P; Bresnihan B; Fitzgerald O
    J Rheumatol; 2001 Apr; 28(4):921-2. PubMed ID: 11327280
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arthritis in definitive systemic lupus erythematosus].
    Haberhauer G
    Z Arztl Fortbild (Jena); 1990; 84(3):85-7. PubMed ID: 2343605
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution of IgG subclasses among human autoantibodies to Sm, RNP, dsDNA, SS-B and IgG rheumatoid factor.
    Yount WJ; Cohen P; Eisenberg RA
    Monogr Allergy; 1988; 23():41-56. PubMed ID: 2968502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases.
    Ramos-Casals M; Nardi N; Brito-Zerón P; Aguiló S; Gil V; Delgado G; Bové A; Font J
    Semin Arthritis Rheum; 2006 Apr; 35(5):312-21. PubMed ID: 16616154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The classification of rheumatic diseases: impact of developments in immunoassays and immunogenetics.
    Kunkel HG
    Hum Pathol; 1983 Apr; 14(4):288-9. PubMed ID: 6339361
    [No Abstract]   [Full Text] [Related]  

  • 13. Fulminant thrombotic thrombocytopenic purpura in two patients with systemic lupus erythematosus and phospholipid autoantibodies.
    Musa MO; Nounou R; Sahovic E; Seth P; Qadi A; Aljurf M
    Eur J Haematol; 2000 Jun; 64(6):433-5. PubMed ID: 10901599
    [No Abstract]   [Full Text] [Related]  

  • 14. The evolution of a case of overlap syndrome with systemic sclerosis, rheumatoid arthritis and systemic lupus erythematosus.
    Gendi N; Gordon T; Tanner SB; Black CM
    Br J Rheumatol; 1992 Nov; 31(11):783-6. PubMed ID: 1450805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathies: renal and extrarenal lesions.
    Droz D; Nochy D; Noël LH; Heudes D; Nabarra B; Hill GS
    Adv Nephrol Necker Hosp; 2000; 30():235-59. PubMed ID: 11068646
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical significance of the anti-Sm antibody].
    Chen DL
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):13-5. PubMed ID: 3109698
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis.
    Graninger WB; Hassfeld W; Pesau BB; Machold KP; Zielinski CC; Smolen JS
    J Rheumatol; 1991 Oct; 18(10):1621-2. PubMed ID: 1765991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to antinuclear subsets in systemic lupus erythematosus and rheumatoid arthritis.
    Smolen JS; Hassfeld W; Graninger W; Steiner G
    Clin Exp Rheumatol; 1990; 8 Suppl 5():41-4. PubMed ID: 2245525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of anti-Sm and anti-DNA antibodies followed by clinical manifestation of systemic lupus erythematosus in an elderly woman with long-standing Sjögren's syndrome.
    Satoh M; Yamagata H; Watanabe F; Nakayama S; Ogasawara T; Tojo T; Akizuki M
    Lupus; 1995 Feb; 4(1):63-5. PubMed ID: 7767341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
    Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
    Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.